Conmed Corp (CNMD)
76.41
-1.03
(-1.33%)
USD |
NYSE |
Mar 18, 16:00
76.43
+0.02
(+0.03%)
After-Hours: 20:00
Price Chart
Key Stats
Price and Performance | |
---|---|
Market Cap | 2.352B |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
All-Time High (Daily) | Upgrade |
Year to Date Total Returns (Daily) | Upgrade |
1 Month Total Returns (Daily) | Upgrade |
1 Year Total Returns (Daily) | -14.66% |
Valuation | |
PE Ratio | 37.47 |
PE Ratio (Forward) | Upgrade |
PS Ratio | 1.937 |
Price to Book Value | 2.820 |
EV to EBITDA | Upgrade |
Dividend | |
---|---|
Dividend | 0.20 |
Dividend Yield (Forward) | Upgrade |
Financials | |
Revenue (5 Year Growth) | Upgrade |
Revenue (Quarterly YoY Growth) | Upgrade |
EPS Diluted (5 Year Growth) | Upgrade |
EPS Diluted (Quarterly YoY Growth) | Upgrade |
Debt to Equity Ratio | 1.167 |
Return on Equity | Upgrade |
Return on Assets | Upgrade |
Risk | |
Beta (5Y) | Upgrade |
Max Drawdown (5Y) | 65.69% |
Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue. |
URL | https://www.conmed.com |
Investor Relations URL | https://www.conmed.com/en/Investor-Relations |
HQ State/Province | Florida |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Small Cap/Blend |
Next Earnings Release | Apr. 26, 2024 (est.) |
Last Earnings Release | Jan. 31, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Mar. 14, 2024 |
Ratings
Profile
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue. |
URL | https://www.conmed.com |
Investor Relations URL | https://www.conmed.com/en/Investor-Relations |
HQ State/Province | Florida |
Sector | Healthcare |
Industry | Medical Devices |
Equity Style | Small Cap/Blend |
Next Earnings Release | Apr. 26, 2024 (est.) |
Last Earnings Release | Jan. 31, 2024 |
Next Ex-Dividend Date | N/A |
Last Ex-Dividend Date | Mar. 14, 2024 |